Skip to main content

DI014

Product Details
WHO Product ID
DI014
Status
Prequalified
INN, dosage form and strength
Zinc (sulfate) Tablet, Dispersible 20mg
Date of prequalification
Basis of listing
Prequalification - Full
Therapeutic area
Diarrhoea
Type
Finished Pharmaceutical Product
Dosage form
Tablet, Dispersible
Applicant organization
Swiss Pharma Nigeria Ltd.
P.O Box 463, Ikeja, 5, Dopemu Road
Agege,
Lagos
100273
Nigeria
Packaging details and storage conditions
Packaging Type
Blister, Alu/PVC/PVdC
Configuration
10x1, 10x10
Shelf life (months)
24
Storage conditions
Do not store above 30°C, protect from moisture, protect from light
API Manufacturing Site(s)
By Organization
By Active Ingredient
Dr Paul Lohmann GmbH & Co KGaA
Haupstrasse 2
Emmerthal,
D-31860
Germany
Zinc (sulfate)
FPP Manufacturing Site(s)
Swiss Pharma Nigeria Ltd.
P.O Box 463, Ikeja, 5, Dopemu Road
Agege,
Lagos
100273
Nigeria
WHO Public Assessment Reports


Part 1 - Abstract
Part 2 - All accepted presentations (including photo)
Part 3 - WHO-PQ recommended patient information leaflet*
Part 4 - WHO-PQ recommended summary of product characteristics*
Part 5 - Label
Part 6 - Discussion (status at the time of prequalification)
Part 7 - Steps before Prequalification
Part 8 - Steps following Prequalification (from 01 March 2014, only changes to the published information are included)

* This summary of product characteristics/patient information leaflet focus on uses of the medicine covered by WHO Prequalification Team - Medicines. The recommendations for use are based on WHO guidelines and on information from stringent regulatory authorities (term to be revised). The medicine may be authorised for additional or different uses by national medicines regulatory authorities. 

Part 1 , Part 2 , Part 3 , Part 4 , Part 5 , Part 6 , Part 7 , Part 8

.